Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
BridgeBio revenue
BridgeBio's revenue is $221.9 million.
What is BridgeBio's revenue?
- BridgeBio's revenue growth from 2019 to 2024 is 447.1%.
- BridgeBio has 396 employees, and the revenue per employee ratio is $560,358.
- BridgeBio's peak quarterly revenue was $211.1M in 2024(q1).
- BridgeBio peak revenue was $221.9M in 2024.
- BridgeBio annual revenue for 2023 was 9.3M, -88.02% growth from 2022.
- BridgeBio annual revenue for 2024 was 221.9M, 2,285.27% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
BridgeBio historical revenue
BridgeBio's peak revenue was $221.9M in 2024. The peak quarterly revenue was $211.1M in 2024(q1).
BridgeBio's revenue increased from $40.6m in 2019 to $221.9M currently. That's a 447.1% change in annual revenue.
BridgeBio annual revenue
BridgeBio annual revenue over time
| Fiscal year / year | BridgeBio revenue |
|---|---|
| 2019 | $40.6M |
| 2020 | $8.2M |
| 2021 | $69.7M |
| 2022 | $77.6M |
| 2023 | $9.3M |
| 2024 | $221.9M |
How accurately did BridgeBio's revenue projections match actual performance?
BridgeBio annual growth
BridgeBio saw the greatest revenue growth in 2021, when revenue increased by 745.14%.
BridgeBio had the lowest revenue growth in 2020, when revenue changed by -79.66%.
BridgeBio annual growth rate over time
| Year | BridgeBio growth |
|---|---|
| 2020 | -80%↓ |
| 2021 | 745%↑ |
| 2022 | 11%↑ |
| 2023 | -88%↓ |
| 2024 | 2285%↑ |
BridgeBio quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
BridgeBio quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | - | - | $26.7M | $13.8M |
| 2020 | - | - | $8.1M | $122,000 |
| 2021 | $462,000 | $54.0M | $2.3M | $12.9M |
| 2022 | $1.7M | $73.7M | $338,000 | $1.9M |
| 2023 | $1.8M | $1.6M | $4.1M | $1.7M |
| 2024 | $211.1M | $2.2M | $2.7M | $5.9M |
BridgeBio jobs nearby
Do you work at BridgeBio?
Did BridgeBio meet its revenue projections?
BridgeBio financial information
| CEO | Eric Michael David |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 396 |
| Date Founded | 2014 |
| Headquarters | Palo Alto, California |
| Number of Locations | 1 |
| Revenue | $221.9M |
| Net Income | -$481,183,000 |
| Gross Proft | $218.0M (2024) |
| Tax Rate | -0.0% |
| Total Assets | $623,036,000 |
| Ticker | BBIO |
BridgeBio jobs you might like
BridgeBio financing
BridgeBio received early financing of $6.9M on 2016-03-01.
| Series | Round size | Date |
|---|---|---|
| Series B | $6.9M | 03/2016 |
| Series B | $33.1M | 05/2017 |
| Series C | $135M | 09/2017 |
| Series D | $299.2M | 01/2019 |
| Post Ipo Debt | $475M | 03/2020 |
| Post Ipo Debt | $250M | 01/2021 |
| Post Ipo Debt | $750M | 11/2021 |
BridgeBio investors
| Investors | Security type |
|---|---|
| KKR & Co. Inc. | Series B |
| KKR & Co. Inc. | Series B |
| Cormorant Capital | Series C |
| Viking Global Investors | Series C |
| Perceptive Advisors | Series C |
| KKR & Co. Inc. | Series C |
| Janus Fund | Series C |
| AIG Investments | Series C |
| Aisling Capital | Series C |
| Cormorant Capital | Series D |
| Viking Global Investors | Series D |
| Perceptive Advisors | Series D |
| KKR & Co. Inc. | Series D |
| Sequoia Capital | Series D |
| Hercules Capital Inc. | Series D |
| AIG Investments | Series D |
| Aisling Capital | Series D |
BridgeBio competitors
BridgeBio's top competitor, Inozyme Pharma, earned an annual revenue of $2.2B.
BridgeBio's smallest competitor is Homology Medicines with revenue of $-6.7M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Homology Medicines | - | ($6.7M) | 124 | - |
| Rocket Pharmaceuticals | - | $11.8M | 50 | - |
| Synlogic | - | $8,000 | 74 | - |
| Retrophin | - | $198.3M | 262 | - |
| Accera | - | $5.5M | 75 | - |
| Inozyme Pharma | - | $2.2B | 20 | - |
| Stealth BioTherapeutics | - | $21.1M | 52 | - |
| Glycomine | - | $400,000 | 8 | - |
| Cerecor | - | $6.7M | 32 | - |
| Ribometrix | - | $2.0M | 44 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
BridgeBio highest paying jobs
Zippia gives an in-depth look into the details of BridgeBio, including salaries, political affiliations, employee data, and more, in order to inform job seekers about BridgeBio. The employee data is based on information from people who have self-reported their past or current employments at BridgeBio. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by BridgeBio. The data presented on this page does not represent the view of BridgeBio and its employees or that of Zippia.
BridgeBio may also be known as or be related to BRIDGEBIO PHARMA, INC., BridgeBio, BridgeBio Inc. and BridgeBio Pharma Inc.